Read more about Novartis to Launch Direct-to-Patient Platform for Cosentyx® (secukinumab) in the US Archives - Pharma Strategies | Zimbabwe | Zambia & beyond!

Posts

Novartis News Novartis to Launch Direct-to-Patient Platform for Cosentyx® (secukinumab) in the US

Novartis to Launch Direct-to-Patient Platform for Cosentyx® (secukinumab) in the US
arcticnovartis
Mon, 09/29/2025 – 14:19

Select units of Cosentyx to be made available at 55% discount off list price on direct-to-patient (DTP) platform beginning November 1, 2025

Print
PDF

September 29, 2025/by arcticnovartis